Catalyst Wire Dossier Catalyst Wire Dossier

WIXELA INHUB

Fluticasone propionate and salmeterol · Mylan Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for WIXELA INHUB, covering 2019-01-30 to 2022-03-31. Get the full timeline:

Most recent: FDA Approved: WIXELA INHUB — Supplemental Application (Mylan Pharmaceuticals Inc.)

See pricing